Bachmann, CJ, Philipsen, A, Hoffmann, F (2017). ADHD in Germany: trends in diagnosis and pharmacotherapy. Deutsches Ärzteblatt International 114, 141–148.
Beau-Lejdstrom, R, Douglas, I, Evans, SJ, Smeeth, L (2016). Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistence. BMJ Open 6, e010508.
Bonati, M, Reale, L, Zanetti, M, Cartabia, M, Fortinguerra, F, Capovilla, G, Chiappedi, M, Costantino, A, Effedri, P, Luoni, C, Martinelli, O, Molteni, M, Ottolini, A, Saccani, M, Lombardy, AG (in press). A regional ADHD center-based network project for the diagnosis and treatment of children and adolescents with ADHD. Journal of Attention Disorders.
Burcu, M, Zito, JM, Metcalfe, L, Underwood, H, Safer, DJ (2016). Trends in stimulant medication use in commercially insured youths and adults, 2010–2014. JAMA Psychiatry 73, 992–993.
Furu, K, Karlstad, O, Zoega, H, Martikainen, JE, Bahmanyar, S, Kieler, H, Pottegard, A (2017). Utilization of stimulants and atomoxetine for attention-deficit/hyperactivity disorder among 5.4 million children using population-based longitudinal data. Basic & Clinical Pharmacology & Toxicology 120, 373–379.
Kovess, V, Choppin, S, Gao, F, Pivette, M, Husky, M, Leray, E (2015). Psychotropic medication use in French children and adolescents. Journal of Child and Adolescent Psychopharmacology 25, 168–175.
Kubo, S, Noda, T, Myojin, T, Nishioka, Y, Higashino, T, Matsui, H, Kato, G, Imamura, T (2018). National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB): Outline and patient-matching technique. https://www.biorxiv.org/content/biorxiv/early/2018/03/29/280008.full.pdf (accessed 10 April 2018).
Lawson, KA, Johnsrud, M, Hodgkins, P, Sasane, R, Crismon, ML (2012). Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid program. Clinical Therapeutics 34, 944–956, e4.
National Institute for Health and Care Excellence (2006). Methylphenidate, Atomoxetine and Dexamfetamine for Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents. British Psychological Society: Leicester.
National Institute for Health and Care Excellence (2018). Attention Deficit Hyperactivity Disorder: Diagnosis and Management. British Psychological Society: Leicester.
Okumura, Y, Sakata, N, Takahashi, K, Nishi, D, Tachimori, H (2017). Epidemiology of overdose episodes from the period prior to hospitalization for drug poisoning until discharge in Japan: an exploratory descriptive study using a nationwide claims database. Journal of Epidemiology 27, 373–380.
Palli, SR, Kamble, PS, Chen, H, Aparasu, RR (2012). Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology 22, 139–148.
Piovani, D, Clavenna, A, Cartabia, M, Bonati, M (2016). Psychotropic medicine prescriptions in Italian youths: a multiregional study. European Child & Adolescent Psychiatry 25, 235–245.
Polanczyk, GV, Salum, GA, Sugaya, LS, Caye, A, Rohde, LA (2015). Annual research review: a meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. Journal of Child Psychology and Psychiatry, and Allied Disciplines 56, 345–365.
Saito, M (2016). Diagnosis and Management for ADHD: Clinical Practice Guideline (in Japanese). Jiho: Tokyo.
Thomas, R, Sanders, S, Doust, J, Beller, E, Glasziou, P (2015). Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics 135, e994–e1001.
Wang, LJ, Yang, KC, Lee, SY, Yang, CJ, Huang, TS, Lee, TL, Yuan, SS, Shyu, YC (2016). Initiation and persistence of pharmacotherapy for youths with attention deficit hyperactivity disorder in Taiwan. PLoS ONE 11, e0161061.
Wang, LJ, Lee, SY, Yuan, SS, Yang, CJ, Yang, KC, Huang, TS, Chou, WJ, Chou, MC, Lee, MJ, Lee, TL, Shyu, YC (2017). Prevalence rates of youths diagnosed with and medicated for ADHD in a nationwide survey in Taiwan from 2000 to 2011. Epidemiology and Psychiatric Sciences 26, 624–634.